Close

Evogene (EVGN) Misses Q4 EPS by 3c

May 26, 2022 7:04 AM EDT

Evogene (NASDAQ: EVGN) reported Q4 EPS of ($0.20), $0.03 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $237 thousand versus the consensus estimate of $270 thousand.

For earnings history and earnings-related data on Evogene (EVGN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings